UK Updates

Great Britain confirms indefinite recognition of CE marked medical devices and IVDs

The UK government confirmed on 21 October 2026 that it will continue to accept CE marked medical devices and in vitro diagnostic devices (IVDs) on the Great Britain market on a long term basis. The decision follows the targeted consultation that ran from 16 February to 10 April 2026, and it affects every manufacturer that […]

Great Britain confirms indefinite recognition of CE marked medical devices and IVDs Read More »

MHRA Fees Consultation 2026: Device Registration Fee Proposed to Rise

On 17 August 2026 the MHRA published a consultation on statutory fees, setting out “proposals for ongoing cost-recovery and to fund higher value services”. The consultation closed on 25 September 2026. For device companies, the headline proposal is an increase in the annual post-market surveillance (PMS) registration fee from £300 to £511 per chargeable GMDN

MHRA Fees Consultation 2026: Device Registration Fee Proposed to Rise Read More »

UK Health Bill: What the New Medical Device Licensing Powers Mean for Manufacturers and Importers

On 1 September 2026 the MHRA announced that the government had tabled regulatory reform amendments to the Health Bill. The most significant for the device sector is an enabling power for a future medical device licensing regime in Great Britain, under which the MHRA could licence devices and certain regulated businesses directly. The amendments also

UK Health Bill: What the New Medical Device Licensing Powers Mean for Manufacturers and Importers Read More »

When Does an AI Scribe Become a Medical Device? The MHRA Draws the Line

On 29 July 2026 the MHRA published guidance on ambient voice technology-enabled products, the AI scribes now appearing across clinical settings. The guidance sets out when these products qualify as medical devices on the Great Britain market, and how they should be classified if they do. The short version is that the line is drawn

When Does an AI Scribe Become a Medical Device? The MHRA Draws the Line Read More »

The MHRA wants in on MDSAP. Here’s what it could mean for your audit strategy

The MHRA has signalled it is moving towards becoming a full member of the Medical Device Single Audit Program (MDSAP). The announcement came at the annual MDSAP Forum in Kyoto in June 2026, where the agency framed the move as a step towards stronger post-market surveillance, earlier risk detection, and closer alignment with comparable regulators

The MHRA wants in on MDSAP. Here’s what it could mean for your audit strategy Read More »

MHRA Publishes Draft Pre-Market Rules for the GB Market

The Medicines and Healthcare products Regulatory Agency (MHRA) has published new pre-market regulatory requirements for medical devices and in vitro diagnostic devices (IVDs) entering the Great Britain market. The draft, titled the Medical Devices (Amendment) Regulations 2026, was notified to the World Trade Organisation TBT portal on Friday 8 May 2026 under reference G/TBT/N/GBR/120, opening

MHRA Publishes Draft Pre-Market Rules for the GB Market Read More »

MHRA and FDA Announce Strengthened Regulatory Cooperation on Medical Devices

The UK Medicines and Healthcare products Regulatory Agency and the US Food and Drug Administration announced strengthened regulatory cooperation on medical devices on 7 April 2026, as part of the wider US-UK trade and partnership framework agreed earlier in the year. The two agencies have committed to exploring closer regulatory alignment and potential mutual recognition

MHRA and FDA Announce Strengthened Regulatory Cooperation on Medical Devices Read More »

UK MHRA Consults on Indefinite Recognition of CE-Marked Medical Devices in Great Britain

Introduction The UK Medicines and Healthcare products Regulatory Agency (MHRA) has published a targeted consultation seeking feedback on proposed updates to the UK medical devices regulatory framework. Among the most notable proposals is the indefinite acceptance of CE-marked medical devices on the Great Britain market. The consultation invites views from manufacturers, importers, distributors, healthcare professionals

UK MHRA Consults on Indefinite Recognition of CE-Marked Medical Devices in Great Britain Read More »